Aevitas Wealth Management, Inc. Gsk PLC Transaction History

Aevitas Wealth Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 26, 2019	SELL	$39.4 - $42.7 $20,842 - $22,588	-529 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$38.57 - $42.69 $38 - $42	1 Added 0.19%	529 $22,000
Q4 2018 Feb 14, 2019	SELL	$37.8 - $42.69 $7,824 - $8,836	-207 Reduced 28.16%	528 $20,000
Q3 2018 Nov 14, 2018	BUY	$39.75 - $42.69 $159 - $170	4 Added 0.55%	735 $30,000
Q2 2018 Aug 10, 2018	BUY	$39.61 - $42.76 $198 - $213	5 Added 0.69%	731 $29,000
Q1 2018 May 15, 2018	BUY	$36.18 - $40.15 $4,558 - $5,058	126 Added 21.0%	726 $28,000
Q4 2017 Feb 13, 2018	BUY	$35.34 - $41.9 $21,204 - $25,140	600	600 $21,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Aevitas Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Aevitas Wealth Management, Inc. with notifications on news.